These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5666934)

  • 21. [Diuretics in cirrhosis. Accidents. Indications].
    Andrieu J; Lesueur G
    Presse Med (1893); 1969 Mar; 77(16):575-8. PubMed ID: 5783378
    [No Abstract]   [Full Text] [Related]  

  • 22. [Urea and spironolactone therapy].
    Schwarzbach W; Bunzl W
    Munch Med Wochenschr; 1973 Jan; 115(3):76-80. PubMed ID: 4739290
    [No Abstract]   [Full Text] [Related]  

  • 23. Effectiveness of high-dose spironolactone therapy in patients with chronic liver disease and relatively refractory ascites.
    Campra JL; Reynolds TB
    Am J Dig Dis; 1978 Nov; 23(11):1025-30. PubMed ID: 31086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversal of the suppressed potassium excretion during treatment with combinations of antikaliuretic drugs (spironolactone, canrenone, triamterene, amiloride) in patients with liver cirrhosis.
    Radó JP; Sawinsky I; Juhos E
    Int J Clin Pharmacol Biopharm; 1976 Oct; 14(3):163-7. PubMed ID: 1002353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prolonged treatment of ascitic cirrhosis by the combination of a saldiuretic and a spironolactone].
    Tolot F; Dechavannes M; Fiere D
    Lyon Med; 1966 Jan; 215(1):29-35. PubMed ID: 5904663
    [No Abstract]   [Full Text] [Related]  

  • 26. Fatal hyperkalemia and hyperchloremic acidosis. Association with spironolactone in the absence of renal impairment.
    Feinfeld DA; Carvounis CP
    JAMA; 1978 Sep; 240(14):1516. PubMed ID: 682358
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of oral isosorbide and intravenous mannitol as adjuncts to the diuresis of patients with cirrhosis of the liver.
    Gagnon O; Gertman PM; Iber FL
    Am J Med Sci; 1967 Sep; 254(3):284-95. PubMed ID: 6054532
    [No Abstract]   [Full Text] [Related]  

  • 28. Opposite effects of spironolactone and amiloride on potassium excretion in a patient with ascites due to liver cirrhosis.
    Radó JP; Juhos E
    Endokrinologie; 1976 Jul; 67(3):377-9. PubMed ID: 976213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can 24-h urine sodium excretion be replaced by spot urine sodium/potassium in patients with decompensated cirrhosis?
    Cholongitas E; Karatapanis S; Nakouti T; Birtsou C; Skorda L; Kouvelis I; Papastergiou V; Papachrysos N; Goulis J; Akriviadis E
    Liver Int; 2012 Jan; 32(1):172-3. PubMed ID: 22098704
    [No Abstract]   [Full Text] [Related]  

  • 30. Use of a new diuretic agent (metolazone) in patients with edema and ascites.
    Lowenthal DT; Shear L
    Arch Intern Med; 1973 Jul; 132(1):38-41. PubMed ID: 4716425
    [No Abstract]   [Full Text] [Related]  

  • 31. Attenuation by spironolactone of the magnesiuric effect of acute frusemide administration in patients with liver cirrhosis and ascites.
    Stergiou GS; Mayopoulou-Symvoulidou D; Mountokalakis TD
    Miner Electrolyte Metab; 1993; 19(2):86-90. PubMed ID: 8377729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of aldactone on potassium storage in patients with ascitic cirrhosis].
    Lévy VG; Lassale B; Del Corso A; Caroli J
    Ann Med Interne (Paris); 1970 Feb; 121(2):183-90. PubMed ID: 5491199
    [No Abstract]   [Full Text] [Related]  

  • 33. [Controlled study of the effect of long-term administration of canrenoate potassium in cirrhotic ascites].
    Traina M; Vizzini GB
    Minerva Med; 1986 Jan; 77(3-4):87-91. PubMed ID: 3511409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Change in antikaliuretic response to potassium-sparing diuretics in patients with cirrhotic ascites.
    Radó JP
    J Am Geriatr Soc; 1976 Aug; 24(8):340-3. PubMed ID: 939897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperkalaemic paralysis due to spironolactone.
    Udezue EO; Harrold BP
    Postgrad Med J; 1980 Apr; 56(654):254-5. PubMed ID: 7433326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Saluretics in liver diseases].
    Dorner M; Frey G
    Munch Med Wochenschr; 1966 Dec; 108(51):2583-4. PubMed ID: 6013308
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of diuretics in the treatment of cirrhotic ascites.
    Boyer TD; Warnock DG
    Gastroenterology; 1983 May; 84(5 Pt 1):1051-5. PubMed ID: 6832557
    [No Abstract]   [Full Text] [Related]  

  • 38. Diagnostic usefulness of the random urine Na/K ratio in predicting therapeutic response for diuretics in cirrhotic patients with ascites.
    Mohii el SM; El Mansy IM; Salah M; Khedr MA
    J Egypt Soc Parasitol; 2013 Dec; 43(3):767-76. PubMed ID: 24640876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
    J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative study of spironolactone and eplerenone in management of ascites in patients of cirrhosis of liver.
    Sehgal R; Singh H; Singh IP
    Eur J Gastroenterol Hepatol; 2020 Apr; 32(4):535-539. PubMed ID: 32044820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.